Active phase definition

Active phase means activities including the extraction, removal, or recovery of metal ore. For surface mines, this definition does not include any land where grading has returned the earth to a desired contour and reclamation has begun.
Sample 1Sample 2Sample 3
Active phase means activities including each step from extraction through production of a salable product.
Sample 1Sample 2
Active phase means the phase where a record is required on a more frequent basis and is typically retained and accessible in the originating department.
Sample 1

Examples of Active phase in a sentence

  • Active phase - Activities including the extraction, removal or recovery of minerals.

  • Friedrich, Active phase and amplitude fluctuations of flagellar beating.

  • Total disturbance area includes areas of land which are within the Active phase.

  • Applicants agree to participate in the BioFleet branding program.

  • M., Active phase evolution in single Ni/Al2O3 methanation catalyst bodies studied in real time using combined μ-XRD-CT and μ-absorption-CT.

  • Figure 5 : Active phase detector, with resistive loadsVarious active phase detectors have thus been designed, based on Gilbert cell mixer and using bipolar devices.

  • Active phase labor arrest: A randomized trial of chorioamnion management.

  • During the Active phase, the control platform is fully supported and maintained by ABB, including but not limited to spare parts and repair services, training services and 24/7 technical support.

  • Experiments not installing significant equipment may not need to advance past the Active phase.

  • For any of your project that is in the "Active" phase, you can access both the technical reporting (deliverables) as the financial one (Form C).


More Definitions of Active phase

Active phase. During the active phase of the net- work, communicating principals may not be con- nected with the TTP due to geographical separation. In this phase, to conserve the energy of the resource constrained MANET nodes, we propose to use ECC based public key cryptographic primitives for gener- ating key pair and symmetric key among MANET nodes and also for generating and verifying signa- tures during authenticated key agreement process. The detailed steps for the proposed two-party authen- ticated key agreement protocol are as follows. • Step 1: Based on the reception of node B’s beacon, node A verifies its hybrid crypto token and sends an authentication request message to node B. • Step 2: Node A selects rA randomly, where 1 ≤ rA ≤ q − 1 and then computes QA = rA · P . Node TABLE III. CIPHER SUITE SELECTION VS ENERGY CONSUMPTION AT NODE LEVEL Token Type Node level Key Type and Size TTP level Key Type and Size Energy Required for SV(mJ) Energy Ratio Energy Reguired for SG(mJ) Energy ratio Proposed hybrid Token ECC-163 RSA-1024 15.97 1:1 134.20 1:1 RSA based Token XXX-0000 XXX-0000 15.97 1:1 546.50 1:4 ECC based Token XXX-000 XXX-000 196.23 1:12 134.20 1:1
Sample 1
Active phase means activities including each step from the extraction through production of a salable product, removal or recovery of metal ore. For surface mines, this definition does not include any land where grading has returned the earth to a desired contour and reclamation has begun.
Sample 1

Related to Active phase

  • Construction Phase means that Phase of the Project which shall commence after the Authority provides the Trade Contractor with written Notice to Proceed with the Construction Phase.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase 2 means the second implementation phase of this section, beginning June 1, 2022 and continuing thereafter.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Operational Acceptance Tests means the tests specified in the Technical Requirements and Agreed Project Plan to be carried out to ascertain whether the System, or a specified Sub system, is able to attain the functional and performance requirements specified in the Technical Requirements and Agreed Project Plan, in accordance with the provisions of GCC Clause 27.2 (Operational Acceptance Test).

  • Contract Year means each period of twelve (12) consecutive months during the Initial Term of this Agreement, with the first Contract Year commencing on the Effective Date, and with each subsequent Contract Year commencing on the anniversary of the Effective Date.

  • Commissioning Period means, with respect to each Subproject, the period commencing upon the first delivery of Feed Gas to the Subproject in accordance with Sections 4.8 and 11.1 of the Agreement continuing through achievement of RFSU, commissioning, Start Up, Performance Testing and achievement of Substantial Completion for such Subproject.

  • Phase 1 means the first implementation phase of this section, beginning June 1, 2018 and ending May 31, 2022.

  • Phase I Clinical Trial means the initial introduction of a Licensed Product as an investigational new drug into humans as required in 21 C.F.R. § 312, designed to determine the metabolism and pharmacologic actions of the Licensed Product in humans, the side effects associated with increasing doses and, if possible, to gain early evidence on effectiveness, and also includes studies of drug metabolism, structure-activity relationships and mechanism of action in humans.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase III Clinical Trial means a human clinical trial, the principal purpose of which is to demonstrate clinically and statistically the efficacy and safety of a Licensed Product for one or more indications in order to obtain Marketing Approval of such Licensed Product for such indication(s), as further defined in 21 C.F.R. §312.21 or a similar clinical study in a country other than the United States.

  • Phase III means human clinical trials, the principal purpose of which is to establish substantial evidence of both safety and efficacy in patients with the disease or condition being studied, as more fully defined in 21 C.F.R. §312.21(c) or similar clinical study in a country other than the United States. Phase III shall also include any other human clinical trial intended to serve as a pivotal trial to support the submission of an application for regulatory approval.

  • Design Phase means the period during which the Transporter shall prepare a draft project proposal for publication in accordance with section 4.3;

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.